Free for academic non-profit institutions. Other users need a Commercial license
The protein encoded by this gene is a member of the serpin family of proteins, a group of proteins that inhibit serine proteases. This gene is one in a cluster of serpin genes located on the q arm of chromosome 14. Polymorphisms in this protein appear to be tissue specific and influence protease targeting. Variations in this protein's sequence have been implicated in Alzheimer's disease, and deficiency of this protein has been associated with liver disease. Mutations have been identified in patients with Parkinson disease and chronic obstructive pulmonary disease. [provided by RefSeq, Jun 2020]
SERPINA3 (Serpin Family A Member 3) is a Protein Coding gene. Diseases associated with SERPINA3 include Malignant Fibrous Histiocytoma and Alpha-1-Antitrypsin Deficiency. Among its related pathways are Response to elevated platelet cytosolic Ca2+ and Immune response_Oncostatin M signaling via JAK-Stat in human cells. Gene Ontology (GO) annotations related to this gene include serine-type endopeptidase inhibitor activity. An important paralog of this gene is SERPINA5.
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0003677 | DNA binding | TAS | 14668352 |
GO:0004867 | serine-type endopeptidase inhibitor activity | IBA,TAS | 2404007 |
GO:0005515 | protein binding | IPI | 12709365 |
GO:0030414 | peptidase inhibitor activity | IEA | -- |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0005576 | extracellular region | TAS | -- |
GO:0005615 | extracellular space | IEA,IDA | 25645918 |
GO:0005634 | nucleus | TAS | 14668352 |
GO:0031093 | platelet alpha granule lumen | TAS | -- |
GO:0034774 | secretory granule lumen | TAS | -- |
SuperPathway | Contained pathways | ||
---|---|---|---|
1 | Response to elevated platelet cytosolic Ca2+ |
.44
|
|
2 | Innate Immune System |
.61
|
|
3 | Folate Metabolism | ||
4 | Development_Thrombopoetin signaling via JAK-STAT pathway |
Development_Thrombopoetin signaling via JAK-STAT pathway
-
|
|
5 | Immune response_Oncostatin M signaling via JAK-Stat in human cells |
Immune response_Oncostatin M signaling via JAK-Stat in human cells
-
|
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0002576 | platelet degranulation | TAS | -- |
GO:0006953 | acute-phase response | IEA | -- |
GO:0006954 | inflammatory response | NAS | 12475184 |
GO:0010466 | negative regulation of peptidase activity | IEA | -- |
GO:0010951 | negative regulation of endopeptidase activity | IBA | 21873635 |
Name | Status | Disease Links | Group | Role | Mechanism of Action | Clinical Trials |
---|---|---|---|---|---|---|
Zinc | Approved, Investigational | Pharma | Target | 1687 | ||
zinc acetate | Approved, Investigational | Pharma | Target | 0 | ||
Zinc chloride | Approved, Investigational | Pharma | Target, binder | 0 | ||
Zinc sulfate, unspecified form | Approved, Experimental | Pharma | Target, binder | 0 | ||
Citric acid | Approved, Vet_approved | Nutra | Target | 1584 |
Name | Synonyms | Role | CAS Number | PubChem IDs | PubMed IDs |
---|
ExUns: | 1a | · | 1b | · | 1c | ^ | 2 | ^ | 3a | · | 3b | · | 3c | ^ | 4a | · | 4b | ^ | 5a | · | 5b | · | 5c | · | 5d | · | 5e | ^ | 6a | · | 6b | · | 6c | ^ | 7 | ^ | 8 | ^ | 9a | · | 9b | · | 9c | · | 9d | ^ | 10 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SP1: | - | - | - | ||||||||||||||||||||||||||||||||||||||||||||
SP2: | - | - | |||||||||||||||||||||||||||||||||||||||||||||
SP3: | - | - | - | - | - | - | - | ||||||||||||||||||||||||||||||||||||||||
SP4: | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||
SP5: | - | - | - | - | |||||||||||||||||||||||||||||||||||||||||||
SP6: | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||||||
SP7: | - | - | - | - | |||||||||||||||||||||||||||||||||||||||||||
SP8: | - | - | |||||||||||||||||||||||||||||||||||||||||||||
SP9: | - | - | - | ||||||||||||||||||||||||||||||||||||||||||||
SP10: | - | - | |||||||||||||||||||||||||||||||||||||||||||||
SP11: | - | ||||||||||||||||||||||||||||||||||||||||||||||
SP12: | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||
SP13: |
This gene was present in the common ancestor of mammals.
Organism | Taxonomy | Gene | Similarity | Type | Details |
---|---|---|---|---|---|
Chimpanzee (Pan troglodytes) |
Mammalia | SERPINA3 30 31 |
|
OneToOne | |
Cow (Bos Taurus) |
Mammalia | SERPINA3-1 30 31 |
|
OneToMany | |
-- 31 |
|
OneToMany | |||
-- 31 |
|
OneToMany | |||
SERPINA3-6 31 |
|
OneToMany | |||
-- 31 |
|
OneToMany | |||
-- 31 |
|
OneToMany | |||
-- 31 |
|
OneToMany | |||
Dog (Canis familiaris) |
Mammalia | SERPINA3 30 31 |
|
OneToOne | |
Mouse (Mus musculus) |
Mammalia | Serpina3n 30 17 31 |
|
OneToMany | |
Serpina3m 17 31 |
|
OneToMany | |||
Serpina3i 31 |
|
OneToMany | |||
Serpina3c 17 31 |
|
OneToMany | |||
Serpina3k 17 31 |
|
OneToMany | |||
Serpina3f 31 |
|
OneToMany | |||
Serpina3g 31 |
|
OneToMany | |||
Serpina3j 31 |
|
OneToMany | |||
Serpina3b 31 |
|
OneToMany | |||
Serpina3a 31 |
|
OneToMany | |||
Rat (Rattus norvegicus) |
Mammalia | Serpina3n 30 |
|
||
Platypus (Ornithorhynchus anatinus) |
Mammalia | -- 31 |
|
OneToMany | |
Oppossum (Monodelphis domestica) |
Mammalia | SERPINA3 31 |
|
OneToOne |
SNP ID | Clinical significance and condition | Chr 14 pos | Variation | AA Info | Type |
---|---|---|---|---|---|
rs112967031 | Benign: not provided | 94,619,373(+) |
A/C NM_001085.5(SERPINA3):c.822A>C (p.Ala274=) |
SYNONYMOUS | |
rs113864331 | Benign: not provided | 94,619,349(+) |
G/A NM_001085.5(SERPINA3):c.798G>A (p.Leu266=) |
SYNONYMOUS | |
rs116929575 | Uncertain Significance: ANTICHYMOTRYPSIN ISEHARA 1; Peripheral arterial occlusive disease 1 | 94,623,782(+) |
A/G NM_001085.5(SERPINA3):c.1240A>G (p.Met414Val) |
MISSENSE | |
rs139747783 | Likely Benign: not provided | 94,619,444(+) |
G/A NM_001085.5(SERPINA3):c.893G>A (p.Arg298Gln) |
MISSENSE | |
rs140884476 | Uncertain Significance: not provided | 94,619,275(+) |
C/A NM_001085.5(SERPINA3):c.724C>A (p.Pro242Thr) |
MISSENSE |
Disorder | Aliases | PubMed IDs |
---|---|---|
malignant fibrous histiocytoma |
|
|
alpha-1-antitrypsin deficiency |
|
|
fibrosarcoma of bone |
|
|
fibrous histiocytoma |
|
|
benign giant cell tumor |
|
|